FDA Sticks Breakthrough Tag on GlaxoSmithKline's Blood Cancer Drug Post author:Sam Post published:November 1, 2017 Post category:BioPharma GSK2857916 is an anti B-cell maturation agent (BCMA) monoclonal antibody-drug conjugate. Source: BioSpace You Might Also Like One-Time CAR-T Leader Juno Shows Off Promising New Clinical Data November 1, 2017 New Wirelessly Powered Scalable Retinal Prosthesis, University of California, San Diego (UCSD) Reveals March 16, 2017 Amgen on a Roll as the FDA OKs Repatha to Prevent Heart Attack and Stroke December 3, 2017
New Wirelessly Powered Scalable Retinal Prosthesis, University of California, San Diego (UCSD) Reveals March 16, 2017
